| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report AH Filipovich, D Weisdorf, S Pavletic, G Socie, JR Wingard, SJ Lee, ... Biology of blood and marrow transplantation 11 (12), 945-956, 2005 | 4091 | 2005 |
| Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis RL Levine, M Wadleigh, J Cools, BL Ebert, G Wernig, BJP Huntly, ... Cancer cell 7 (4), 387-397, 2005 | 3814 | 2005 |
| A phase 2 study of bortezomib in relapsed, refractory myeloma PG Richardson, B Barlogie, J Berenson, S Singhal, S Jagannath, D Irwin, ... New England Journal of Medicine 348 (26), 2609-2617, 2003 | 3435 | 2003 |
| National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working … MH Jagasia, HT Greinix, M Arora, KM Williams, D Wolff, EW Cowen, ... Biology of Blood and Marrow Transplantation 21 (3), 389-401. e1, 2015 | 2445 | 2015 |
| American Society of Clinical Oncology recommendations on fertility preservation in cancer patients SJ Lee, LR Schover, AH Partridge, P Patrizio, WH Wallace, K Hagerty, ... Journal of clinical oncology 24 (18), 2917-2931, 2006 | 2378 | 2006 |
| MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia Y Pikman, BH Lee, T Mercher, E McDowell, BL Ebert, M Gozo, A Cuker, ... PLoS medicine 3 (7), e270, 2006 | 1755 | 2006 |
| High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation SJ Lee, J Klein, M Haagenson, LA Baxter-Lowe, DL Confer, M Eapen, ... Blood, The Journal of the American Society of Hematology 110 (13), 4576-4583, 2007 | 1530 | 2007 |
| Chronic graft-versus-host disease SJ Lee, G Vogelsang, MED Flowers Biology of Blood and Marrow Transplantation 9 (4), 215-233, 2003 | 1063 | 2003 |
| Peripheral-blood stem cells versus bone marrow from unrelated donors C Anasetti, BR Logan, SJ Lee, EK Waller, DJ Weisdorf, JR Wingard, ... New England Journal of Medicine 367 (16), 1487-1496, 2012 | 991 | 2012 |
| Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology JD Rizzo, AE Lichtin, SH Woolf, J Seidenfeld, CL Bennett, D Cella, ... Blood, The Journal of the American Society of Hematology 100 (7), 2303-2320, 2002 | 854 | 2002 |
| A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved … CS Cutler, SJ Lee, P Greenberg, HJ Deeg, WS Pérez, C Anasetti, ... Blood 104 (2), 579-585, 2004 | 822 | 2004 |
| Risk factors for acute GVHD and survival after hematopoietic cell transplantation M Jagasia, M Arora, MED Flowers, NJ Chao, PL McCarthy, CS Cutler, ... Blood, The Journal of the American Society of Hematology 119 (1), 296-307, 2012 | 789 | 2012 |
| Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation NS Majhail, JD Rizzo, SJ Lee, M Aljurf, Y Atsuta, C Bonfim, LJ Burns, ... Revista brasileira de hematologia e hemoterapia 34, 109-133, 2012 | 742 | 2012 |
| Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation RC Lindsley, W Saber, BG Mar, R Redd, T Wang, MD Haagenson, ... New England Journal of Medicine 376 (6), 536-547, 2017 | 700 | 2017 |
| Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse SJ Lee, JP Klein, AJ Barrett, O Ringden, JH Antin, JY Cahn, MH Carabasi, ... Blood, The Journal of the American Society of Hematology 100 (2), 406-414, 2002 | 660 | 2002 |
| Reduced frequency of FOXP3+ CD4+ CD25+ regulatory T cells in patients with chronic graft-versus-host disease E Zorn, HT Kim, SJ Lee, BH Floyd, D Litsa, S Arumugarajah, R Bellucci, ... Blood 106 (8), 2903-2911, 2005 | 564 | 2005 |
| Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft … HM Shulman, D Kleiner, SJ Lee, T Morton, SZ Pavletic, E Farmer, ... Biology of Blood and Marrow Transplantation 12 (1), 31-47, 2006 | 520 | 2006 |
| Rituximab for steroid-refractory chronic graft-versus-host disease C Cutler, D Miklos, HT Kim, N Treister, SB Woo, D Bienfang, LB Klickstein, ... Blood 108 (2), 756-762, 2006 | 513 | 2006 |
| Antibody responses to HY minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission DB Miklos, HT Kim, KH Miller, L Guo, E Zorn, SJ Lee, EP Hochberg, ... Blood 105 (7), 2973-2978, 2005 | 485 | 2005 |
| Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic … SZ Pavletic, P Martin, SJ Lee, S Mitchell, D Jacobsohn, EW Cowen, ... Biology of Blood and Marrow Transplantation 12 (3), 252-266, 2006 | 454 | 2006 |
